In CRC, LEF1 orchestrates glycolytic reprograming and EMT-associated phenotypic transformation, forming a synergistic network with mitochondrial dysfunction that collectively drives CT resistance in CRC. This evidence concerns the gene LEF1 and colorectal carcinoma.